v3.25.4
Acquisitions
 12 Months Ended
Dec. 31, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Acquisitions

3. Acquisitions

 

Acquisition of Access Point Technologies EP, Inc. (“APT”):

 

On July 31, 2024, the Company acquired all the shares of capital stock of Access Point Technologies EP, Inc. (“APT”), a Minnesota corporation, from APT Holding Company, Inc., a Minnesota corporation. APT designs, manufactures, and commercializes a portfolio of differentiated high-quality diagnostic catheters used during cardiac ablation procedures that are commercially available across key global geographies.

 

 

The acquisition of APT was accounted for as a business combination using the acquisition method of accounting. The consideration included an upfront payment and additional contingent payments based upon the achievement of key regulatory and commercial milestones. At closing, the Company issued 1,486,620 shares of its common stock (the “Upfront Stock Consideration”) with a fair value of $3.0 million. The Share Purchase Agreement obligated us to file a resale registration statement relating to the Upfront Stock Consideration and additional shares of our common stock as earnout consideration (the “Earnout Shares”). The registration statement covered the 1,486,620 Closing Shares and an estimated 4,613,380 additional Earnout Shares. However, the exact number of shares that may be issued under the Share Purchase Agreement for such milestones will be calculated based on the average of the closing per share price of Stereotaxis common stock immediately prior to the dates such revenue performance and/or regulatory milestones are achieved, up to $24.0 million in total value through September 30, 2029, not to exceed 19.9% of the total number of shares of the Company’s common stock issued and outstanding immediately prior to July 31, 2024 (the “Share Cap Limitation”). In addition, the vesting of the right to receive the Earnout Shares would be accelerated in the event of a change of control of Stereotaxis, based on a probability-weighted average estimate of the potential to achieve any remaining milestones, discounted to its net present value taking into account expected time when earnouts related to the milestones would become payable through September 30, 2029. The estimated fair value of the contingent consideration related to the additional Earnout Shares at the acquisition date was $10.0 million. The total contingent consideration, including the upfront payment is estimated to be $13.0 million.

 

The following table summarizes the estimated fair value of the assets acquired and liabilities assumed for APT as of the acquisition date (in thousands):

 

     
Assets acquired:    
Current assets    
Cash  $108 
Accounts receivable, net of allowance of $19   693 
Inventories, net   1,607 
Prepaid expenses and other current assets   1 
Total current assets   2,409 
Property and equipment   825 
Goodwill   3,764 
Intangible assets   7,740 
Total assets acquired  $14,738 
Liabilities assumed:     
Current liabilities     
Accounts payable  $1,723 
Accrued liabilities   49 
Total liabilities assumed  $1,772 
Net assets acquired  $12,966 

 

The above purchase price allocation was final as of June 30, 2025. No measurement period adjustments were recognized during the six months ended June 30, 2025. For purposes of the above allocation, we based our estimate of the fair values for contingent consideration, intangible assets, and property and equipment on valuation studies performed by third-party valuation firms. We used various valuation methods, including discounted cash flows, distributor method, excess earnings, and relief from royalty method to estimate the fair value of the identified intangible assets. The fair value of the contingent consideration was determined using a Monte Carlo simulation and probability based approaches. The Cost approach was utilized to determine the fair value of property and equipment. Goodwill and other intangible assets reflected above were determined to meet the criteria for recognition apart from tangible assets acquired and liabilities assumed. The goodwill is primarily attributable to APT’s in-house research and development team versus using third party developers and the expansion of manufacturing capacity. The tax basis in the acquired goodwill is zero.

 

 

The following represents the pro forma consolidated revenue as if APT had been included in the consolidated results of the Company. Revenue was $29.9 million for the year ended December 31, 2024. The Company incurred acquisition costs of $0.5 million that were recognized within General and Administrative expenses for the year ended December 31, 2024.

 

The intangible assets related to the acquisition consisted of the following:

 

(in thousands)  Fair Value   Amortization Period 
Intangible assets subject to amortization:  (in thousands)   (in years) 
Developed technology  $6,250    7.0 - 8.0 
Customer relationships   310    10.0 
Trademark   410    5.0 
Total intangible assets subject to amortization  $6,970      
Intangible assets not subject to amortization          
In process research and development   770     N/A  
Goodwill  $3,764     N/A  
Total intangible assets not subject to amortization   4,534      
Total intangible assets  $11,504      
Weighted average amortization period        7.7 

 

On August 7, 2025, Stereotaxis, Inc, in accordance with Section 2.5(b) of the May 11, 2024, Share Purchase Agreement among Stereotaxis, Inc, Access Point Technologies EP, Inc. and APT Holding Company, Inc., issued 417,710 shares of common stock as payment of a part of the earnout consideration payable to APT Holding, Inc.

 

On October 29, 2025, Stereotaxis, Inc, in accordance with Section 2.5(c) of the May 11, 2024, Share Purchase Agreement among Stereotaxis, Inc, Access Point Technologies EP, Inc. and APT Holding Company, Inc., issued 1,001,813 shares of common stock as payment of a part of the earnout consideration payable to APT Holding, Inc.

 

The Company recognized expense of $2.2 million and $1.8 million for the years ended December 31, 2025 and 2024, respectively, due to the revaluation of contingent consideration. This expense is recognized within General and Administrative expenses.